HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20+
SponsorFar Eastern Memorial Hospital

About this trial

Therefore, the aim of this study is to assess the therapeutic effect on overactive bladder symptoms, sexual function, heart rate variability, arterial stiffness, atherosclerosis, sleep, and depression between tibolone and E2V/MPA.

From the results, the investigators will compare the effect of tibolone versus E2V/MPA on overactive bladder symptoms, sexual function, autonomic function, arterial stiffness, atherosclerosis, sleep and depression.

Eligibility criteria

Qualifiers

>20 years old female

Menopausal symptoms, still have a uterus, and no breast or other cancers, and no vascular-blocking disease such as stroke.

Disqualifiers

Nil.

Trial design

Treatments tested in this trial

  • Tibolone 2.5 mg
  • Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators